Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04359758 · ClinicalTrials.gov registry record · NA
Streamlined Genetic Testing in Prostate Cancer
A NA study, sponsored by Georgetown University.
- Completed
- Registry status
- NA
- Development phase
- 112
- Enrollment target
NCT04359758 is a NA study that has completed, run by Georgetown University. The registered enrollment target is 112 participants.
The verdict
NCT04359758, a NA study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 112 participants
- Enrollment target
Study Summary
The goal of this pilot randomized controlled trial is to evaluate the impact and efficacy of a streamlined genetic education and testing intervention for men with prostate cancer. Eligible men are prostate cancer survivors who meet criteria for genetic counseling referral. After completing a baseline survey, participants (n=120) are randomized to Streamlined Genetic Testing (ST) or Usual Care (UC). Participants in ST are able to review genetic education materials and then proceed directly to genetic testing. Participants in UC will be provided with a referral for standard individual genetic counseling. Two months after randomization all participants will be contacted to complete a follow-up survey.
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL Proactive Streamlined Genetic Education and Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 112 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04359758
The ClinicalTrials.gov registry entry for NCT04359758 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT04359758 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04359758 about?
NCT04359758 is a clinical study titled "Streamlined Genetic Testing in Prostate Cancer". The goal of this pilot randomized controlled trial is to evaluate the impact and efficacy of a streamlined genetic education and testing intervention for men with prostate cancer. Eligible men are prostate cancer survivors who meet criteria for genetic counseling referral. After completing a baselin...
What is the current status of trial NCT04359758?
This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2020-03-01. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT04359758?
The interventions under investigation include: Usual Care (BEHAVIORAL), Proactive Streamlined Genetic Education and Testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT04359758?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.